Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of brozopent sodium injection in acute ischemic stroke
CTR20251210Phase 2Completed
- Sponsor
- Zhejiang Ausun Pharmaceutical
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brozopent sodium in ischemic stroke, sponsored by Zhejiang Ausun Pharmaceutical. Started Jun 2025; status: completed.
02
Drugs
brozopent sodium
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20251210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251210.